3115 GP2-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organosulfur compounds | 1 | 0.1 | 7.04× | not tested | |
| Mixed metal/non-metal compounds | 1 | 0.1 | 6.90× | not tested | |
| Homogeneous metal compounds | 5 | 3.4 | 1.48× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 1.9 | 0.52× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00131 | AMP | Adenosine phosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 138 |
| OHX | osmium (III) hexammine | 73 |
| SPD | SPERMIDINE | 9 |
| AMP | ADENOSINE MONOPHOSPHATE | 2 |
| GET | GENETICIN | 2 |
| Kmetal | POTASSIUM ION | 2 |
| PAR | PAROMOMYCIN | 2 |
| SCN | THIOCYANATE ION | 2 |
| 84G | Arbekacin | 1 |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO-6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)-5-METHYL-4-(METHYLAMINO)-TETRAHYDRO-2H-PYRAN-3,5-DIOL | 1 |
| NAmetal | SODIUM ION | 1 |